112 related articles for article (PubMed ID: 2917984)
1. Chiral nature of covalent methylphosphonyl conjugates of acetylcholinesterase.
Berman HA; Decker MM
J Biol Chem; 1989 Mar; 264(7):3951-6. PubMed ID: 2917984
[TBL] [Abstract][Full Text] [Related]
2. Chiral reactions of acetylcholinesterase probed with enantiomeric methylphosphonothioates. Noncovalent determinants of enzyme chirality.
Berman HA; Leonard K
J Biol Chem; 1989 Mar; 264(7):3942-50. PubMed ID: 2917983
[TBL] [Abstract][Full Text] [Related]
3. Mechanism of oxime reactivation of acetylcholinesterase analyzed by chirality and mutagenesis.
Wong L; Radic Z; Brüggemann RJ; Hosea N; Berman HA; Taylor P
Biochemistry; 2000 May; 39(19):5750-7. PubMed ID: 10801325
[TBL] [Abstract][Full Text] [Related]
4. Amino acid residues controlling reactivation of organophosphonyl conjugates of acetylcholinesterase by mono- and bisquaternary oximes.
Ashani Y; Radić Z; Tsigelny I; Vellom DC; Pickering NA; Quinn DM; Doctor BP; Taylor P
J Biol Chem; 1995 Mar; 270(11):6370-80. PubMed ID: 7890775
[TBL] [Abstract][Full Text] [Related]
5. Specificity and orientation of trigonal carboxyl esters and tetrahedral alkylphosphonyl esters in cholinesterases.
Hosea NA; Berman HA; Taylor P
Biochemistry; 1995 Sep; 34(36):11528-36. PubMed ID: 7547883
[TBL] [Abstract][Full Text] [Related]
6. Mutant cholinesterases possessing enhanced capacity for reactivation of their phosphonylated conjugates.
Kovarik Z; Radić Z; Berman HA; Simeon-Rudolf V; Reiner E; Taylor P
Biochemistry; 2004 Mar; 43(11):3222-9. PubMed ID: 15023072
[TBL] [Abstract][Full Text] [Related]
7. Aspartate 74 as a primary determinant in acetylcholinesterase governing specificity to cationic organophosphonates.
Hosea NA; Radić Z; Tsigelny I; Berman HA; Quinn DM; Taylor P
Biochemistry; 1996 Aug; 35(33):10995-1004. PubMed ID: 8718893
[TBL] [Abstract][Full Text] [Related]
8. Phosphoryl oxime inhibition of acetylcholinesterase during oxime reactivation is prevented by edrophonium.
Luo C; Saxena A; Smith M; Garcia G; Radić Z; Taylor P; Doctor BP
Biochemistry; 1999 Aug; 38(31):9937-47. PubMed ID: 10433700
[TBL] [Abstract][Full Text] [Related]
9. Kinetic, equilibrium, and spectroscopic studies on dealkylation ("aging") of alkyl organophosphonyl acetylcholinesterase. Electrostatic control of enzyme topography.
Berman HA; Decker MM
J Biol Chem; 1986 Aug; 261(23):10646-52. PubMed ID: 3733723
[TBL] [Abstract][Full Text] [Related]
10. Ligand exclusion on acetylcholinesterase.
Berman HA; Leonard K
Biochemistry; 1990 Nov; 29(47):10640-9. PubMed ID: 2271673
[TBL] [Abstract][Full Text] [Related]
11. Mutation of acetylcholinesterase to enhance oxime-assisted catalytic turnover of methylphosphonates.
Kovarik Z; Radić Z; Berman HA; Taylor P
Toxicology; 2007 Apr; 233(1-3):79-84. PubMed ID: 17046138
[TBL] [Abstract][Full Text] [Related]
12. Kinetic, equilibrium and spectroscopic studies on cation association at the active center of acetylcholinesterase: topographic distinction between trimethyl and trimethylammonium sites.
Berman HA; Decker MM
Biochim Biophys Acta; 1986 Jul; 872(1-2):125-33. PubMed ID: 3089281
[TBL] [Abstract][Full Text] [Related]
13. Fluorescent phosphonate labels for serine hydrolases. Kinetic and spectroscopic properties of (7-nitrobenz-2-oxa-1,3-diazole)aminoalkyl methylphosphonofluoridates and their conjugates with acetylcholinesterase molecular forms.
Berman HA; Olshefski DF; Gilbert M; Decker MM
J Biol Chem; 1985 Mar; 260(6):3462-8. PubMed ID: 3972833
[TBL] [Abstract][Full Text] [Related]
14. Limitations in current acetylcholinesterase structure-based design of oxime antidotes for organophosphate poisoning.
Kovalevsky A; Blumenthal DK; Cheng X; Taylor P; Radić Z
Ann N Y Acad Sci; 2016 Aug; 1378(1):41-49. PubMed ID: 27371941
[TBL] [Abstract][Full Text] [Related]
15. Site selectivity of fluorescent bisquaternary phenanthridinium ligands for acetylcholinesterase.
Berman HA; Decker MM; Nowak MW; Leonard KJ; McCauley M; Baker WM; Taylor P
Mol Pharmacol; 1987 Jun; 31(6):610-6. PubMed ID: 3600605
[TBL] [Abstract][Full Text] [Related]
16. Counteracting tabun inhibition by reactivation by pyridinium aldoximes that interact with active center gorge mutants of acetylcholinesterase.
Kovarik Z; Maček Hrvat N; Kalisiak J; Katalinić M; Sit RK; Zorbaz T; Radić Z; Fokin VV; Sharpless KB; Taylor P
Toxicol Appl Pharmacol; 2019 Jun; 372():40-46. PubMed ID: 30978400
[TBL] [Abstract][Full Text] [Related]
17. The characterization of Lucilia cuprina acetylcholinesterase as a drug target, and the identification of novel inhibitors by high throughput screening.
Ilg T; Cramer J; Lutz J; Noack S; Schmitt H; Williams H; Newton T
Insect Biochem Mol Biol; 2011 Jul; 41(7):470-83. PubMed ID: 21530657
[TBL] [Abstract][Full Text] [Related]
18. Docking study of enantiomeric fonofos oxon bound to the active site of Torpedo californica acetylcholinesterase.
Hirashima A; Kuwano E; Eto M
Bioorg Med Chem; 2000 Mar; 8(3):653-6. PubMed ID: 10732982
[TBL] [Abstract][Full Text] [Related]
19. Resolving pathways of interaction of covalent inhibitors with the active site of acetylcholinesterases: MALDI-TOF/MS analysis of various nerve agent phosphyl adducts.
Elhanany E; Ordentlich A; Dgany O; Kaplan D; Segall Y; Barak R; Velan B; Shafferman A
Chem Res Toxicol; 2001 Jul; 14(7):912-8. PubMed ID: 11453739
[TBL] [Abstract][Full Text] [Related]
20. Exploring the active center of human acetylcholinesterase with stereomers of an organophosphorus inhibitor with two chiral centers.
Ordentlich A; Barak D; Kronman C; Benschop HP; De Jong LP; Ariel N; Barak R; Segall Y; Velan B; Shafferman A
Biochemistry; 1999 Mar; 38(10):3055-66. PubMed ID: 10074358
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]